Chicago Partners Investment Group LLC Cue Biopharma, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.84 Billion
- Q1 2025
A detailed history of Chicago Partners Investment Group LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 90,302 shares of CUE stock, worth $61,405. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,302Holding current value
$61,405% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CUE
# of Institutions
52Shares Held
11.5MCall Options Held
10.1KPut Options Held
1.4K-
Bleichroeder LP New York, NY5MShares$3.4 Million1.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$1.57 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$514,5800.0% of portfolio
-
Geode Capital Management, LLC Boston, MA694KShares$471,8450.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$325,3800.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $24.1M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...